CoChat

Targeting tumors that lack methylthioadenosine phosphorylase (MTAP) activity: Current strategies

Open access
Bertino, Joseph R., Waud, William R., Parker, William B., Lubin, Martin · 2011 · Cancer Biology & Therapy
Cited by 150

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Many solid tumors and hematologic malignancies lack expression of the enzyme methylthioadenosine phosphorylase (MTAP), due either to deletion of the MTAP gene or to methylation of the MTAP promoter. In cells that have MTAP, its natural substrate, methylthioadenosine (MTA), generated during polyamine biosynthesis, is cleaved to adenine and 5-methylthioribose-1-phosphate. The latter compound is further metabolized to methionine. Adenine and methionine are further metabolized and hence salvaged. In MTAP-deficient cells, however, MTA is not cleaved and the salvage pathway for adenine and methionine is absent. As a result, MTAP-deficient cells are more sensitive than MTAP-positive cells to inhibitors of de novo purine synthesis and to methionine deprivation. The challenge has been to take advantage of MTAP deficiency, and the changes in metabolism that follow, to design a strategy for targeted treatment. In this review, the frequency of MTAP-deficiency is presented and past and recent strategies to target such deficient cells are discussed, including one in which MTA is administered, followed by very high doses of a toxic purine or pyrimidine analog. In normal host cells, adenine, generated from MTA, blocks conversion of the analog to its toxic nucleotide. In MTAP-deficient tumor cells, conversion proceeds and the tumor cells are selectively killed. Successful mouse studies using this novel strategy were recently reported.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4161/cbt.11.7.14948

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 47

  1. 10.1007/978-1-4684-5637-0_16 · doi:10.1007/978-1-4684-5637-0_16
  2. Chen ZH, 1996, Cancer Res, 56, 1083
  3. Illei PB, 2003, Clin Cancer Res, 9, 2108
  4. 10.1016/j.lungcan.2008.04.019 · DOI
  5. García-Castellano JM, 2002, Clin Cancer Res, 8, 782
  6. Miyazaki S, 2007, Int J Oncol, 5, 1069
  7. 10.1016/j.cancergencyto.2005.10.009 · doi:10.1016/j.cancergencyto.2005.10.009
  8. 10.1007/s12253-008-9113-1 · DOI
  9. Nobori T, 1991, Cancer Res, 51, 3193
  10. 10.1158/1078-0432.CCR-09-1511 · DOI
  11. 10.1159/000009983 · DOI
  12. 10.1097/01.pas.0000170349.47680.e8 · DOI · Paper page
  13. 10.1002/path.2679 · DOI
  14. 10.1158/1535-7163.MCT-05-0103 · DOI · Paper page
  15. 10.1016/S0002-9440(10)63695-4 · DOI
  16. 10.1038/sj.onc.1202205 · DOI
  17. Ishii M, 2005, Int J Oncol, 26, 985
  18. 10.1124/mol.52.5.903 · DOI
  19. 10.1016/0006-2952(83)90396-9 · doi:10.1016/0006-2952(83)90396-9
  20. 10.1038/sj.leu.2401771 · DOI
  21. Traweek ST, 1988, Blood, 71, 1568, 10.1182/blood.V71.6.1568.1568 · doi:10.1182/blood.v71.6.1568.1568
  22. 10.1002/(SICI)1097-0215(19980105)75:1<51::AID-IJC9>3.0.CO;2-0 · DOI · Paper page
  23. 10.1002/(SICI)1098-2264(199805)22:1<72::AID-GCC10>3.0.CO;2-K · DOI
  24. Mirebeau D, 2006, Haematologica, 91, 881
  25. 10.1158/1078-0432.CCR-05-2780 · doi:10.1158/1078-0432.ccr-05-2780
  26. 10.1158/0008-5472.CAN-09-0145 · DOI · Paper page
  27. 10.1016/j.cancergencyto.2010.03.002 · doi:10.1016/j.cancergencyto.2010.03.002
  28. Hori H, 1996, Cancer Res, 56, 5653
  29. 10.1073/pnas.82.15.4881 · DOI · Paper page
  30. 10.1126/science.273.5278.1109 · DOI · Paper page
  31. 10.1097/00000421-198304000-00009 · DOI
  32. 10.1097/00000421-198410000-00030 · DOI
  33. Creagan ET, 1983, Cancer Treat Rep, 67, 1047
  34. 10.1007/BF00194553 · DOI
  35. 10.1158/1535-7163.MCT-06-0343 · DOI · Paper page
  36. Tan CT, 1994, J Clin Oncol, 12, 1955, 10.1200/JCO.1994.12.9.1955 · doi:10.1200/jco.1994.12.9.1955
  37. 10.1158/1078-0432.CCR-04-0972 · DOI
  38. 10.1016/S0168-8278(00)00078-7 · DOI
  39. Wolford RW, 1984, Exp Hematol, 12, 867
  40. 10.1002/ana.20895 · DOI
  41. 10.1186/1471-2407-10-265 · DOI
  42. 10.1124/mol.108.054411 · DOI
  43. 10.1073/pnas.78.2.1219 · DOI
  44. 10.1371/journal.pone.0005735 · DOI
  45. Lubin M, 2009, Proc Am Assoc Cancer Res, 4, e5735
  46. 10.1002/1097-0142(195611/12)9:6<1092::AID-CNCR2820090605>3.0.CO;2-1 · doi:10.1002/1097-0142(195611/12)9:6<1092::aid-cncr2820090605>3.0.co;2-1
  47. Bertino JR, 2010, Proc Am Assoc Cancer Res, 5393

Cited by

See all 150

Metadata

Authors
Bertino, J. R., Waud, W. R., Parker, W. B., & Lubin, M.
Venue
Cancer Biology & Therapy
Published
2011-04
Volume
11
Issue
7
Pages
627-632
ISSN
  • 1538-4047 (ISSN-L)
  • 1555-8576
OpenAlex
W2047073318
Cited by
150
References
3
FWCI
2.47
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.